Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 127 entries
Sorted by: Best Match Show Resources per page
Erratum to: High Resolution Melting Analysis is Very Useful to Identify BRCA1 c.4964_4982del19 (rs80359876) Founder Calabrian Pathogenic Variant on Peripheral Blood and Buccal Swab DNA.

Molecular diagnosis & therapy

Minucci A, De Bonis M, De Paolis E, Gentile L, Santonocito C, Concolino P, Mignone F, Capoluongo E.
PMID: 28266003
Mol Diagn Ther. 2017 Apr;21(2):233. doi: 10.1007/s40291-017-0273-0.

No abstract available.

Cite
Minucci A, De Bonis M, De Paolis E, et al. Erratum to: High Resolution Melting Analysis is Very Useful to Identify BRCA1 c.4964_4982del19 (rs80359876) Founder Calabrian Pathogenic Variant on Peripheral Blood and Buccal Swab DNA. Mol Diagn Ther. 2017;21(2):233doi: 10.1007/s40291-017-0273-0.
Minucci, A., De Bonis, M., De Paolis, E., Gentile, L., Santonocito, C., Concolino, P., Mignone, F., & Capoluongo, E. (2017). Erratum to: High Resolution Melting Analysis is Very Useful to Identify BRCA1 c.4964_4982del19 (rs80359876) Founder Calabrian Pathogenic Variant on Peripheral Blood and Buccal Swab DNA. Molecular diagnosis & therapy, 21(2), 233. https://doi.org/10.1007/s40291-017-0273-0
Minucci, Angelo, et al. "Erratum to: High Resolution Melting Analysis is Very Useful to Identify BRCA1 c.4964_4982del19 (rs80359876) Founder Calabrian Pathogenic Variant on Peripheral Blood and Buccal Swab DNA." Molecular diagnosis & therapy vol. 21,2 (2017): 233. doi: https://doi.org/10.1007/s40291-017-0273-0
Minucci A, De Bonis M, De Paolis E, Gentile L, Santonocito C, Concolino P, Mignone F, Capoluongo E. Erratum to: High Resolution Melting Analysis is Very Useful to Identify BRCA1 c.4964_4982del19 (rs80359876) Founder Calabrian Pathogenic Variant on Peripheral Blood and Buccal Swab DNA. Mol Diagn Ther. 2017 Apr;21(2):233. doi: 10.1007/s40291-017-0273-0. PMID: 28266003.
Copy Download .nbib Format: NLM
Human papillomavirus typing of invasive cervical cancers in Italy.

Infectious agents and cancer

Del Mistro A, Salamanca HF, Trevisan R, Bertorelle R, Parenti A, Bonoldi E, Zambon P, Minucci D.
PMID: 17192187
Infect Agent Cancer. 2006 Dec 27;1:9. doi: 10.1186/1750-9378-1-9.

BACKGROUND: Human papilloma viruses (HPV) are the necessary cause of invasive cervical cancer (ICC). Of the many different types identified so far, only a few of them account for the great majority of cases worldwide, with geographical differences in...

Cite
Del Mistro A, Salamanca HF, Trevisan R, et al. Human papillomavirus typing of invasive cervical cancers in Italy. Infect Agent Cancer. 2006;1:9doi: 10.1186/1750-9378-1-9.
Del Mistro, A., Salamanca, H. F., Trevisan, R., Bertorelle, R., Parenti, A., Bonoldi, E., Zambon, P., & Minucci, D. (2006). Human papillomavirus typing of invasive cervical cancers in Italy. Infectious agents and cancer, 19. https://doi.org/10.1186/1750-9378-1-9
Del Mistro, Annarosa, et al. "Human papillomavirus typing of invasive cervical cancers in Italy." Infectious agents and cancer vol. 1 (2006): 9. doi: https://doi.org/10.1186/1750-9378-1-9
Del Mistro A, Salamanca HF, Trevisan R, Bertorelle R, Parenti A, Bonoldi E, Zambon P, Minucci D. Human papillomavirus typing of invasive cervical cancers in Italy. Infect Agent Cancer. 2006 Dec 27;1:9. doi: 10.1186/1750-9378-1-9. PMID: 17192187; PMCID: PMC1769356.
Copy Download .nbib Format: NLM
EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma.

Advances in hematology

Mannucci S, Luzzi A, Carugi A, Gozzetti A, Lazzi S, Malagnino V, Simmonds M, Cusi MG, Leoncini L, van den Bosch CA, De Falco G.
PMID: 22593768
Adv Hematol. 2012;2012:149780. doi: 10.1155/2012/149780. Epub 2012 Apr 24.

Burkitt lymphoma is endemic in the Equatorial Belt of Africa, its molecular hallmark is an activated, MYC gene mostly due to a chromosomal translocation. Especially in its endemic clinical variant, Burkitt lymphoma is associated with the oncogenic Epstein-Barr virus...

Cite
Mannucci S, Luzzi A, Carugi A, et al. EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. Adv Hematol. 2012;2012:149780doi: 10.1155/2012/149780.
Mannucci, S., Luzzi, A., Carugi, A., Gozzetti, A., Lazzi, S., Malagnino, V., Simmonds, M., Cusi, M. G., Leoncini, L., van den Bosch, C. A., & De Falco, G. (2012). EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. Advances in hematology, 2012149780. https://doi.org/10.1155/2012/149780
Mannucci, Susanna, et al. "EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma." Advances in hematology vol. 2012 (2012): 149780. doi: https://doi.org/10.1155/2012/149780
Mannucci S, Luzzi A, Carugi A, Gozzetti A, Lazzi S, Malagnino V, Simmonds M, Cusi MG, Leoncini L, van den Bosch CA, De Falco G. EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. Adv Hematol. 2012;2012:149780. doi: 10.1155/2012/149780. Epub 2012 Apr 24. PMID: 22593768; PMCID: PMC3347697.
Copy Download .nbib Format: NLM
Preliminary molecular evidence associating a novel BRCA1 synonymous variant with hereditary ovarian cancer syndrome.

Human genome variation

Minucci A, Concolino P, De Bonis M, Costella A, Paris I, Scambia G, Capoluongo E.
PMID: 29760936
Hum Genome Var. 2018 Apr 20;5:2. doi: 10.1038/s41439-018-0003-0. eCollection 2018.

Extensive molecular screening of the

Cite
Minucci A, Concolino P, De Bonis M, et al. Preliminary molecular evidence associating a novel BRCA1 synonymous variant with hereditary ovarian cancer syndrome. Hum Genome Var. 2018;5:2doi: 10.1038/s41439-018-0003-0.
Minucci, A., Concolino, P., De Bonis, M., Costella, A., Paris, I., Scambia, G., & Capoluongo, E. (2018). Preliminary molecular evidence associating a novel BRCA1 synonymous variant with hereditary ovarian cancer syndrome. Human genome variation, 52. https://doi.org/10.1038/s41439-018-0003-0
Minucci, Angelo, et al. "Preliminary molecular evidence associating a novel BRCA1 synonymous variant with hereditary ovarian cancer syndrome." Human genome variation vol. 5 (2018): 2. doi: https://doi.org/10.1038/s41439-018-0003-0
Minucci A, Concolino P, De Bonis M, Costella A, Paris I, Scambia G, Capoluongo E. Preliminary molecular evidence associating a novel BRCA1 synonymous variant with hereditary ovarian cancer syndrome. Hum Genome Var. 2018 Apr 20;5:2. doi: 10.1038/s41439-018-0003-0. eCollection 2018. PMID: 29760936; PMCID: PMC5938031.
Copy Download .nbib Format: NLM
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial.

Journal of clinical medicine

Cerchione C, Martinelli G, Picardi M, Pugliese N, Nappi D, Casoria A, Gravetti A, Cangini D, Giannini MB, Ronconi S, Simonetti G, Ghelli Luserna Di Rorà A, De Giorgi U, Altini M, Bravaccini S, Santoriello I, Minucci C, Pane F, Martinelli V.
PMID: 32024148
J Clin Med. 2020 Feb 01;9(2). doi: 10.3390/jcm9020395.

Bone marrow aspiration and biopsy (BMAB) is a painful procedure, and the routinely used local infiltration anesthesia (LIA) with lidocaine is unable to provide pain relief during the most uncomfortable phases. The primary endpoint of the present randomized, patient-blinded...

Cite
Cerchione C, Martinelli G, Picardi M, et al. Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial. J Clin Med. 2020;9(2)doi: 10.3390/jcm9020395.
Cerchione, C., Martinelli, G., Picardi, M., Pugliese, N., Nappi, D., Casoria, A., Gravetti, A., Cangini, D., Giannini, M. B., Ronconi, S., Simonetti, G., Ghelli Luserna Di Rorà, A., De Giorgi, U., Altini, M., Bravaccini, S., Santoriello, I., Minucci, C., Pane, F., & Martinelli, V. (2020). Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial. Journal of clinical medicine, 9(2), . https://doi.org/10.3390/jcm9020395
Cerchione, Claudio, et al. "Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial." Journal of clinical medicine vol. 9,2 (2020). doi: https://doi.org/10.3390/jcm9020395
Cerchione C, Martinelli G, Picardi M, Pugliese N, Nappi D, Casoria A, Gravetti A, Cangini D, Giannini MB, Ronconi S, Simonetti G, Ghelli Luserna Di Rorà A, De Giorgi U, Altini M, Bravaccini S, Santoriello I, Minucci C, Pane F, Martinelli V. Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial. J Clin Med. 2020 Feb 01;9(2). doi: 10.3390/jcm9020395. PMID: 32024148; PMCID: PMC7074337.
Copy Download .nbib Format: NLM
Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity.

Endocrine connections

Pascut D, Tamini S, Bresolin S, Giraudi P, Basso G, Minocci A, Tiribelli C, Grugni G, Sartorio A.
PMID: 30352401
Endocr Connect. 2018 Dec 01;7(12):1262-1274. doi: 10.1530/EC-18-0329.

Prader-Willi syndrome (PWS) represents the most common genetic-derived obesity disorder caused by the loss of expression of genes located on the paternal chromosome 15q11.2-q13. The PWS phenotype shows peculiar physical, endocrine and metabolic characteristics compared to those observed in...

Cite
Pascut D, Tamini S, Bresolin S, et al. Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity. Endocr Connect. 2018;7(12):1262-1274doi: 10.1530/EC-18-0329.
Pascut, D., Tamini, S., Bresolin, S., Giraudi, P., Basso, G., Minocci, A., Tiribelli, C., Grugni, G., & Sartorio, A. (2018). Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity. Endocrine connections, 7(12), 1262-1274. https://doi.org/10.1530/EC-18-0329
Pascut, Devis, et al. "Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity." Endocrine connections vol. 7,12 (2018): 1262-1274. doi: https://doi.org/10.1530/EC-18-0329
Pascut D, Tamini S, Bresolin S, Giraudi P, Basso G, Minocci A, Tiribelli C, Grugni G, Sartorio A. Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity. Endocr Connect. 2018 Dec 01;7(12):1262-1274. doi: 10.1530/EC-18-0329. PMID: 30352401; PMCID: PMC6240145.
Copy Download .nbib Format: NLM
Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness.

Frontiers in medicine

Tini G, Duso BA, Bellerba F, Corso F, Gandini S, Minucci S, Pelicci PG, Mazzarella L.
PMID: 32695791
Front Med (Lausanne). 2020 Jun 29;7:367. doi: 10.3389/fmed.2020.00367. eCollection 2020.

No abstract available.

Cite
Tini G, Duso BA, Bellerba F, et al. Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness. Front Med (Lausanne). 2020;7:367doi: 10.3389/fmed.2020.00367.
Tini, G., Duso, B. A., Bellerba, F., Corso, F., Gandini, S., Minucci, S., Pelicci, P. G., & Mazzarella, L. (2020). Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness. Frontiers in medicine, 7367. https://doi.org/10.3389/fmed.2020.00367
Tini, Giulia, et al. "Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness." Frontiers in medicine vol. 7 (2020): 367. doi: https://doi.org/10.3389/fmed.2020.00367
Tini G, Duso BA, Bellerba F, Corso F, Gandini S, Minucci S, Pelicci PG, Mazzarella L. Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness. Front Med (Lausanne). 2020 Jun 29;7:367. doi: 10.3389/fmed.2020.00367. eCollection 2020. PMID: 32695791; PMCID: PMC7336807.
Copy Download .nbib Format: NLM
Antioxidant Activity of Citrus Limonoids and Investigation of Their Virucidal Potential against SARS-CoV-2 in Cellular Models.

Antioxidants (Basel, Switzerland)

Magurano F, Sucameli M, Picone P, Micucci M, Baggieri M, Marchi A, Bucci P, Gioacchini S, Catinella G, Borgonovo G, Dallavalle S, Nuzzo D, Pinto A.
PMID: 34829666
Antioxidants (Basel). 2021 Nov 10;10(11). doi: 10.3390/antiox10111794.

The COVID-19 pandemic represents an unprecedented global emergency. Despite all efforts, COVID-19 remains a threat to public health, due to the complexity of mass vaccination programs, the lack of effective drugs, and the emergence of new variants. A link...

Cite
Magurano F, Sucameli M, Picone P, et al. Antioxidant Activity of Citrus Limonoids and Investigation of Their Virucidal Potential against SARS-CoV-2 in Cellular Models. Antioxidants (Basel). 2021;10(11)doi: 10.3390/antiox10111794.
Magurano, F., Sucameli, M., Picone, P., Micucci, M., Baggieri, M., Marchi, A., Bucci, P., Gioacchini, S., Catinella, G., Borgonovo, G., Dallavalle, S., Nuzzo, D., & Pinto, A. (2021). Antioxidant Activity of Citrus Limonoids and Investigation of Their Virucidal Potential against SARS-CoV-2 in Cellular Models. Antioxidants (Basel, Switzerland), 10(11), . https://doi.org/10.3390/antiox10111794
Magurano, Fabio, et al. "Antioxidant Activity of Citrus Limonoids and Investigation of Their Virucidal Potential against SARS-CoV-2 in Cellular Models." Antioxidants (Basel, Switzerland) vol. 10,11 (2021). doi: https://doi.org/10.3390/antiox10111794
Magurano F, Sucameli M, Picone P, Micucci M, Baggieri M, Marchi A, Bucci P, Gioacchini S, Catinella G, Borgonovo G, Dallavalle S, Nuzzo D, Pinto A. Antioxidant Activity of Citrus Limonoids and Investigation of Their Virucidal Potential against SARS-CoV-2 in Cellular Models. Antioxidants (Basel). 2021 Nov 10;10(11). doi: 10.3390/antiox10111794. PMID: 34829666; PMCID: PMC8615075.
Copy Download .nbib Format: NLM
Hibiscus Flower and Olive Leaf Extracts Activate Apoptosis in SH-SY5Y Cells.

Antioxidants (Basel, Switzerland)

Chiaino E, Micucci M, Budriesi R, Mattioli LB, Marzetti C, Corsini M, Frosini M.
PMID: 34943065
Antioxidants (Basel). 2021 Dec 07;10(12). doi: 10.3390/antiox10121962.

Compounds of natural origin may constitute an interesting tool for the treatment of neuroblastoma, the most prevalent extracranial solid tumor in children. PRES is a commercially available food supplement, composed of a 13:2 (

Cite
Chiaino E, Micucci M, Budriesi R, et al. Hibiscus Flower and Olive Leaf Extracts Activate Apoptosis in SH-SY5Y Cells. Antioxidants (Basel). 2021;10(12)doi: 10.3390/antiox10121962.
Chiaino, E., Micucci, M., Budriesi, R., Mattioli, L. B., Marzetti, C., Corsini, M., & Frosini, M. (2021). Hibiscus Flower and Olive Leaf Extracts Activate Apoptosis in SH-SY5Y Cells. Antioxidants (Basel, Switzerland), 10(12), . https://doi.org/10.3390/antiox10121962
Chiaino, Elda, et al. "Hibiscus Flower and Olive Leaf Extracts Activate Apoptosis in SH-SY5Y Cells." Antioxidants (Basel, Switzerland) vol. 10,12 (2021). doi: https://doi.org/10.3390/antiox10121962
Chiaino E, Micucci M, Budriesi R, Mattioli LB, Marzetti C, Corsini M, Frosini M. Hibiscus Flower and Olive Leaf Extracts Activate Apoptosis in SH-SY5Y Cells. Antioxidants (Basel). 2021 Dec 07;10(12). doi: 10.3390/antiox10121962. PMID: 34943065.
Copy Download .nbib Format: NLM
Hibiscus Flower and Olive Leaf Extracts Activate Apoptosis in SH-SY5Y Cells.

Antioxidants (Basel, Switzerland)

Chiaino E, Micucci M, Budriesi R, Mattioli LB, Marzetti C, Corsini M, Frosini M.
PMID: 34943065
Antioxidants (Basel). 2021 Dec 07;10(12). doi: 10.3390/antiox10121962.

Compounds of natural origin may constitute an interesting tool for the treatment of neuroblastoma, the most prevalent extracranial solid tumor in children. PRES is a commercially available food supplement, composed of a 13:2 (

Cite
Chiaino E, Micucci M, Budriesi R, et al. Hibiscus Flower and Olive Leaf Extracts Activate Apoptosis in SH-SY5Y Cells. Antioxidants (Basel). 2021;10(12)doi: 10.3390/antiox10121962.
Chiaino, E., Micucci, M., Budriesi, R., Mattioli, L. B., Marzetti, C., Corsini, M., & Frosini, M. (2021). Hibiscus Flower and Olive Leaf Extracts Activate Apoptosis in SH-SY5Y Cells. Antioxidants (Basel, Switzerland), 10(12), . https://doi.org/10.3390/antiox10121962
Chiaino, Elda, et al. "Hibiscus Flower and Olive Leaf Extracts Activate Apoptosis in SH-SY5Y Cells." Antioxidants (Basel, Switzerland) vol. 10,12 (2021). doi: https://doi.org/10.3390/antiox10121962
Chiaino E, Micucci M, Budriesi R, Mattioli LB, Marzetti C, Corsini M, Frosini M. Hibiscus Flower and Olive Leaf Extracts Activate Apoptosis in SH-SY5Y Cells. Antioxidants (Basel). 2021 Dec 07;10(12). doi: 10.3390/antiox10121962. PMID: 34943065; PMCID: PMC8750347.
Copy Download .nbib Format: NLM
Corticosteroid prophylaxis for fetal immaturity in a pregnant patient with atrial myxoma.

Journal of cardiology cases

Di Giammarco G, Marchetti M, Foschi M, Marinelli D, Micucci D, Buca D, Leombroni M, Di Mauro M.
PMID: 30546607
J Cardiol Cases. 2015 Sep 19;13(3):67-69. doi: 10.1016/j.jccase.2015.08.012. eCollection 2016 Mar.

We report a case of a woman at 32nd gestational week, admitted for resting dyspnea, showing left atrial (LA) myxoma. Cardiac myxomas are the most common primary benign tumors of the heart. The incidence of cardiac myxomas diagnosed in...

Cite
Di Giammarco G, Marchetti M, Foschi M, et al. Corticosteroid prophylaxis for fetal immaturity in a pregnant patient with atrial myxoma. J Cardiol Cases. 2015;13(3):67-69doi: 10.1016/j.jccase.2015.08.012.
Di Giammarco, G., Marchetti, M., Foschi, M., Marinelli, D., Micucci, D., Buca, D., Leombroni, M., & Di Mauro, M. (2016). Corticosteroid prophylaxis for fetal immaturity in a pregnant patient with atrial myxoma. Journal of cardiology cases, 13(3), 67-69. https://doi.org/10.1016/j.jccase.2015.08.012
Di Giammarco, Gabriele, et al. "Corticosteroid prophylaxis for fetal immaturity in a pregnant patient with atrial myxoma." Journal of cardiology cases vol. 13,3 (2016): 67-69. doi: https://doi.org/10.1016/j.jccase.2015.08.012
Di Giammarco G, Marchetti M, Foschi M, Marinelli D, Micucci D, Buca D, Leombroni M, Di Mauro M. Corticosteroid prophylaxis for fetal immaturity in a pregnant patient with atrial myxoma. J Cardiol Cases. 2015 Sep 19;13(3):67-69. doi: 10.1016/j.jccase.2015.08.012. eCollection 2016 Mar. PMID: 30546607; PMCID: PMC6280735.
Copy Download .nbib Format: NLM
Editorial.

General and comparative endocrinology

Minucci S, Pestarino M, Pierantoni R.
PMID: 33264649
Gen Comp Endocrinol. 2021 Feb 01;302:113666. doi: 10.1016/j.ygcen.2020.113666. Epub 2020 Nov 29.

No abstract available.

Cite
Minucci S, Pestarino M, Pierantoni R. Editorial. Gen Comp Endocrinol. 2020;302:113666doi: 10.1016/j.ygcen.2020.113666.
Minucci, S., Pestarino, M., & Pierantoni, R. (2021). Editorial. General and comparative endocrinology, 302113666. https://doi.org/10.1016/j.ygcen.2020.113666
Minucci, Sergio, et al. "Editorial." General and comparative endocrinology vol. 302 (2021): 113666. doi: https://doi.org/10.1016/j.ygcen.2020.113666
Minucci S, Pestarino M, Pierantoni R. Editorial. Gen Comp Endocrinol. 2021 Feb 01;302:113666. doi: 10.1016/j.ygcen.2020.113666. Epub 2020 Nov 29. PMID: 33264649.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 127 entries